Paul D. Burgess

This profile gathers the share dealings of Paul D. Burgess across 2 companies, led by Cerevel Therapeutics Holdings, Inc. and Translate Bio, Inc. The record holds 4 filings, for trades running from 14 September 2021 to 1 August 2024.

On the open market, the record shows 1 purchase worth €458k and 1 sale worth €2.3M. Taken together, the sales exceed the purchases by €1.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 option exercise.

On 5 August 2024 came the latest disclosure, a transaction in Cerevel Therapeutics Holdings, Inc. The last insider purchase was made public on 7 August 2023, 1,174 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.